Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Cannabis stocks are notoriously volatile. On Aug. 1, 2018, Tilray — a Canadian company that calls itself "one of the largest and most sophisticated producers of premium medical cannabis in the world" — was worth $1.66 billion.
By the numbers: A mere 35 trading days later, on Sept. 20, it was worth $16.37 billion. Today, it's worth $3.3 billion.
Look past the day-to-day volatility in individual stocks, however, and a bigger picture appears: The marijuana sector as a whole, as valued on mostly Canadian stock exchanges, is not only enormous but pretty stable in size.
- The 8 largest companies, collectively worth $39 billion today, have been worth somewhere between $36 billion and $44 billion pretty much all year.
The bottom line: This might well be a bubble. But if it is, we've moved past the get-rich-quick stage. Pot valuations aren't soaring any longer — but they're not declining, either.
Go deeper:
Correction: The chart at the top of this story previously misidentified one of the cannabis companies. Its name is Curaleaf, not Cura Cannabis.